Strategic Clinical Trials Programme Manager (Hybrid)

THE INSTITUTE OF CANCER RESEARCH; London; On-site; GBP 65,000 - 90,000; Full time

Job summary

The Institute of Cancer Research in Sutton, Surrey is seeking an experienced Clinical Trials Programme Manager to lead the ICR-CTSU portfolio and drive multi-centre trials. You will join the Management Group and oversee strategic development, initiation of new trials, and operational oversight of trial teams to ensure timely delivery in a dynamic academic environment.

The role is office-based with possible hybrid arrangements after training, offering the chance to influence high-profile cancer

Qualifications

• First degree or equivalent level qualification in life science or health related subject and understanding of UK Clinical Trials Regulations, GCP, Data Protection, Research Governance and the Human Tissue Act.
• Experience/knowledge of laboratory quality systems and procedures is highly desirable.
• Excellent interpersonal skills and ability to work to high standards across a variety of tasks with constant regard to scientific and regulatory requirements.
• Proven track record in the planning, coordination and conduct of clinical trials within the NHS or academia, a CRO or a pharmaceutical company is essential.

Responsibilities

• The strategic oversight of a defined programme of research within the ICR-CTSU portfolio.
• The development and initiation of new trials.
• Providing operational oversight of dedicated trials teams to ensure successful trial delivery.

Skills

Interpersonal skills

Multi-centre trials experience

Trial oversight

Education

First degree in life science

Job description

The Institute of Cancer Research in Sutton, Surrey is seeking an experienced Clinical Trials Programme Manager to lead the ICR-CTSU portfolio and drive multi-centre trials. You will join the Management Group and oversee strategic development, initiation of new trials, and operational oversight of trial teams to ensure timely delivery in a dynamic academic environment.

The role is office-based with possible hybrid arrangements after training, offering the chance to influence high-profile cancer